# Immunogenicity of ND1.1 by Delivery Directly to the Ileum

> **NCT01698060** · PHASE1 · COMPLETED · sponsor: **Vaxart** · enrollment: 12 (actual)

## Conditions studied

- Avian Influenza

## Interventions

- **BIOLOGICAL:** ND1.1

## Key facts

- **NCT ID:** NCT01698060
- **Lead sponsor:** Vaxart
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01698060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01698060, "Immunogenicity of ND1.1 by Delivery Directly to the Ileum". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01698060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*